PharmTech Drug Digest 11.20
|Articles|April 17, 2015

New Vacuum-Decay Test System Improves Package Leak Detection

PTI's next-generation VeriPac Inspection System, the VeriPac 310, uses new vacuum-decay technology to increase leak-detection accuracy for a range of flexible and rigid packages and containers.

PTI's VeriPac Inspection System, the VeriPac 310, is a new model that replaces the first-generation VeriPac 225 and 325 test systems. The VeriPac 310 uses new vacuum decay technology based on ASTM F2338-09 to provide the most accurate vacuum decay solutions to a broader market and improve leak detectability, flexibility of the test method, and overall performance of a VeriPac test system, the company said in a press release. Features include a new operator interface with enhanced data collection options. The test system is easy to operate and validate and offers maximum test sensitivity for a wide range of both flexible and rigid packages and containers.

The VeriPac 310 instrument connects to a test chamber designed for the specific package shape and size for maximum sensitivity. Test chambers can be manually operated or use automated test fixtures. The 310 is also available with the drawer-style test chamber featured in PTI's D-Series test systems that is designed to test dry-filled, flexible packaging (e.g., pouches, stick packs, sachets).

Source: PTI


Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.